| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 07/05/2011 | CA2606147C Apoptosis promoters |
| 07/05/2011 | CA2531484C Novel bioisosteres of actinonin |
| 07/05/2011 | CA2476583C Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 07/05/2011 | CA2446136C Pyruvate derivatives |
| 07/05/2011 | CA2400185C Androgen receptor suppressors in the therapy and diagnosis of prostate cancer, alopecia and other hyper-androgenic syndromes |
| 06/30/2011 | US20110160207 Heterocyclic amide compounds useful as kinase inhibitors |
| 06/30/2011 | US20110160186 Methods of Treating CYP2D6 Alternative Metabolizers |
| 06/30/2011 | US20110160154 Substituted piperazines |
| 06/30/2011 | CA2784600A1 New inhibitors of cyclophilins and uses thereof |
| 06/29/2011 | EP2338886A2 Naphthalene derivatives |
| 06/29/2011 | EP1326834B1 2-substituted heterocyclic compounds |
| 06/29/2011 | CN1914185B Piperazino photoinitiation sensitisers |
| 06/29/2011 | CN1812974B N-{'4-substituted piperazine-1-sulfonylmethyl]alkyl}-N-hydroxyformamide compounds as metalloproteinase inhibitors |
| 06/29/2011 | CN102112455A Process for preparing cycloalkyl-substituted piperazine compounds |
| 06/29/2011 | CN101565410B Preparation method for 1-piperazine acetyl pyrrolidine |
| 06/29/2011 | CN101502798B Nano ruthenium carbon-supported metal hydrogenating catalyst and method for producing the same |
| 06/28/2011 | US7968601 Treating excess cortisol formation; obesity, cardiovascular disorders, glaucoma, osteoporosis, Alzheimer's Disease; antidiabetic agents |
| 06/28/2011 | US7968547 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 06/28/2011 | US7968538 Substituted arylamine compounds and methods of treatment |
| 06/28/2011 | US7968534 Sulfonamide derivatives, preparation thereof and use thereof as antagonists of orexin 2 receptors |
| 06/28/2011 | US7968001 Stabilizers for the stabilization of unsaturated hydrocarbon-based precursor |
| 06/28/2011 | CA2635196C Glucocorticoid receptor modulators |
| 06/28/2011 | CA2427206C Sulfamides as gamma-secretase inhibitors |
| 06/23/2011 | WO2011073705A1 Novel process for the preparation of piperazine compounds and hydrochloride salts thereof |
| 06/23/2011 | WO2011072791A1 Sphingosine kinase inhibitors |
| 06/23/2011 | WO2010063403A8 Radioisotope-labeled lysine and ornithine derivatives, their use and processes for their preparation |
| 06/23/2011 | US20110152291 Novel aromatic compounds and their use in medical applications |
| 06/23/2011 | US20110152255 Therapeutic compounds |
| 06/23/2011 | US20110152245 Substituted benzamides |
| 06/23/2011 | US20110151258 Preparation of ranolazine |
| 06/23/2011 | US20110151022 Thiotungstate analogues and uses thereof |
| 06/23/2011 | US20110145970 Detection and use of low molecular-weight modulators of the cold-menthol receptor trpm8 |
| 06/23/2011 | CA2784075A1 Inhibitors of sphingosine kinase |
| 06/22/2011 | EP2334659A2 Phenyl malonic acid derivatives |
| 06/22/2011 | EP2334637A1 Novel potassium channel blockers |
| 06/22/2011 | EP2334378A2 Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use |
| 06/22/2011 | EP2334301A1 Macrocyclics pyrimidines as aurora kinase inhibitors |
| 06/22/2011 | EP1505057B1 Method of purifying quaternary alkylammonium salt |
| 06/22/2011 | CN102105485A Selective caspase inhibitors and uses thereof |
| 06/22/2011 | CN102105456A Aryl-sulphonamidic dimers as metalloproteases inhibitors |
| 06/22/2011 | CN102105436A Fatty acid derivatives for oral administration endowed with high paia- tability |
| 06/22/2011 | CN102105174A Diagnostic agents selective against metalloproteases |
| 06/22/2011 | CN102101847A Method for preparing N-methyl-N'-(2-chloroethyl)piperazine |
| 06/22/2011 | CN102100695A High-safety medicinal composition of cinepazide, and preparation method and application thereof |
| 06/22/2011 | CN101601984B Nonylphenol polyoxyethylene ether dimeric surfactant using piperazine as connecting group |
| 06/21/2011 | US7964646 3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 06/21/2011 | US7964605 Phenyl piperazine compounds, pharmaceutical composition comprising the same, and use thereof |
| 06/21/2011 | US7964599 Therapeutic compounds |
| 06/21/2011 | US7964597 Piperazinyl-sulfonamide derivatives useful in the treatment of GPR38 receptor mediated diseases |
| 06/21/2011 | CA2599498C Pyroglutamate salts and their use in the optical resolution of intermediates for the synthesis of dextrocetirizine and levocetirizine |
| 06/21/2011 | CA2563000C Indene derivatives and process for the preparation thereof |
| 06/21/2011 | CA2465641C Phenoxy amine compounds and compositions for delivering active agents |
| 06/21/2011 | CA2444899C Substituted tetracycline compounds for the treatment of malaria |
| 06/21/2011 | CA2359115C Acyl derivatives which treat vla-4 related disorders |
| 06/16/2011 | WO2011071136A1 Therapeutic agent for fibromyalgia |
| 06/16/2011 | WO2011070177A2 Methods of facilitating neural cell survival using gdnf family ligand (gfl) mimetics or ret signaling pathway activators |
| 06/16/2011 | WO2010130260A3 Stable forms of n-(2,6-dimethyl-4-morpholin-4-yl-phenyl)-3,3-dimethyl-butyramide |
| 06/16/2011 | US20110144337 Processes for the preparation of 2,5-dihydroxybenzenesulfonic acid salts |
| 06/16/2011 | CA2783934A1 Methods of facilitating neural cell survival using gdnf family ligand (gfl) mimetics or ret signaling pathway activators |
| 06/15/2011 | EP2332912A1 Heteroarylaminosulfonylphenylderivates for use as sodium or calcium channel blockers in the treatment of pain |
| 06/15/2011 | EP2332540A1 Administration of ranolazine for the treatment of diabetes |
| 06/15/2011 | EP2330894A1 Compositions including 6-aminohexanoic acid derivatives as hdac inhibitors |
| 06/15/2011 | CN102093320A Soluble epoxide hydrolase inhibitor |
| 06/15/2011 | CN102093311A Method for preparing paramorpholinyl sulfoacylmethyl biphenyl |
| 06/15/2011 | CN102093246A Ester compound, preparation method and application thereof |
| 06/15/2011 | CN102093150A Method for synthesizing aromatic amine |
| 06/15/2011 | CN101177385B Aryl sulfonic acid amides and analogues as well as its purpose in curing neural degeneration disease |
| 06/15/2011 | CN101108835B Method of manufacturing high purity hydrochloric acid sarafloxacin |
| 06/15/2011 | CN101104598B Process for preparing trans-4-amino-1-cyclohexanecarboxilic acid derivatives |
| 06/15/2011 | CN101061090B Process for producing alpha, alpha-difluoroamine |
| 06/14/2011 | US7960588 Benzyl cycloalkyl sphingosine 1-phosphate receptor modulators |
| 06/14/2011 | US7960433 Treatment of chemokine mediated diseases |
| 06/14/2011 | US7960412 Selective estrogen receptor modulator |
| 06/14/2011 | US7960389 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders |
| 06/14/2011 | US7960385 Guanidine-containing compounds useful as muscarinic receptor antagonists |
| 06/14/2011 | US7960369 Receptor function regulator |
| 06/14/2011 | CA2496676C 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 06/09/2011 | WO2011068561A1 Sulfonamide derivatives as bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases |
| 06/09/2011 | WO2011067306A1 Cyclohexane derivatives as inhibitors of acetyl-coa carboxylase (acc) |
| 06/09/2011 | WO2011066735A1 An Amorolfine HCl Crystal and the Preparation thereof |
| 06/09/2011 | US20110137030 Catalyst and process for preparing an amine |
| 06/09/2011 | US20110137029 Catalyst and process for preparing an amine |
| 06/09/2011 | US20110136827 Bis-Acylated Hydroxylamine Derivatives |
| 06/09/2011 | US20110136792 Novel carboxylic acid analogs as glycogen synthase activators |
| 06/09/2011 | US20110135650 Morpholinone compounds as factor ixa inhibitors |
| 06/09/2011 | CA2778586A1 Sulfonamide derivatives as bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases |
| 06/08/2011 | EP2328873A2 Preparation of ranolazine |
| 06/08/2011 | EP1879895B1 Enzyme inhibitors |
| 06/08/2011 | CN1829703B (Thio)carbamoyl-cyclohexane derivatives as D3/D2 receptor antagonists |
| 06/08/2011 | CN102089278A Compounds and compositions useful for the treatment of malaria |
| 06/08/2011 | CN102086178A Cinepazide maleate disesquihydrate and preparation method thereof |
| 06/08/2011 | CN101268061B Process to prepare amino acid derivatives |
| 06/07/2011 | US7956093 For example, N-(1-Carbamoyl-1-oxo-3-phenylpropan-2-yl)-2-(E-2-(4-(1-pyrrolidinylmethyl)phenyl)ethen-1-yl)benzamide; calcium channel blockers; cardiovascular disorders; antiarthritic agents; inhibitors of enzymes, especially cysteine proteases such as calpain and cathepsins |
| 06/07/2011 | US7956057 Imidazole compounds |
| 06/03/2011 | WO2011065905A1 Solid forms of 4-{(r)-(3-aminophenyl)[4-(4-fluorobenzyl)-piperazin-1-yl]methyl}-n,n-diethylbenzamide, compositions thereof, and uses therewith |
| 06/02/2011 | US20110130482 Process for preparing armatic thiophenyl ketones |
| 06/01/2011 | EP2327701A1 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 06/01/2011 | EP2327677A1 Mono-nitration of aromatic compounds |
| 06/01/2011 | CN1997370B Use of n-sulfamoyl-n'-arylpiperazines in preparing medicine for the prophylaxis or treatment of obesity and related conditions |
| 06/01/2011 | CN102083807A Therapeutic compounds |